Proactive Costs of Care Intervention Among Patients With Gynecologic Cancer on Active Therapy

What is the Purpose of this Study?

This study focuses on patients diagnosed with gynecologic cancer who are currently receiving treatment at Cedars-Sinai. The purpose of the study is to evaluate the Proactive Costs of Care (PCOC) educational booklet and cost tracker; these materials were developed using feedback from patients, caregivers, and health care members. Researchers want to know whether the educational materials and session help patients feel more confident dealing with financial concerns, improves understanding of health insurance, or reduces financial distress. Patients will be asked to participate in a 30-minute educational session with a trained educator, who will help them identify top practical concerns and provide guidance through the PCOC materials that are most relevant. The PCOC booklet and cost tracker includes information on understanding how to use insurance, dealing with employment concerns, finding personal and community support, and tracking out-of-pocket costs. Participants will also be asked to complete a total of 2 questionnaires (one before the educational session and one 3 months after the educational session) to determine their confidence in dealing with these issues.


Eligibility

  • * Individuals 18 years old or older are included.
  • * Individuals diagnosed with gynecologic cancer
  • * On active systemic therapy within 30 days of enrollment
  • * Receiving treatment at Cedars-Sinai Medical Center
Show more

Where can I participate?

Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

IIT2024-11-Liang-PCOC: An open, single-arm, single-site study to evaluate the Proactive Costs of Care intervention delivered by a trained lay educator to test feasibility with the goal of improving self-efficacy among patients with gynecologic cancer on active therapy

Study Details
Disease Type/Condition

Other

Principal Investigator

Liang, Margaret

Age Group

Adult

Phase

N/A

IRB Number

STUDY00003960

ClinicalTrials.gov ID

NCT07217262

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Other

Principal Investigator

Liang, Margaret

Age Group

Adult

Phase

N/A

IRB Number

IIT2024-11-LIANG-PCOC

ClinicalTrials.gov ID

NCT07217262

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org